< Back to companies
MyMonitor.ai

MyMonitor.ai

Skin diagnosis in 5 seconds

Philadelphia, Pennsylvania, United States

MyMonitor.ai is an AI-powered dermatology and clinical research platform that utilizes multispectral imaging technology for melanin-aware lesion detection. It processes skin analysis in under 5 seconds and achieves high agreement with board-certified dermatologists.

Share
Shareable draft
Get Involved in MyMonitor.ai

Problem Statement

Addressing equity gaps in diagnostics and clinical research for people with skin of color, improving dermatological diagnosis speed and accuracy, and enhancing diverse clinical trial enrollment.

Core Technology

Multispectral imaging technology for melanin-aware lesion detection

Key Differentiators

Processes skin analysis in under 5 seconds; Achieves κ > 0.90 agreement with board-certified dermatologists; Achieves 60% faster diagnosis compared to standard dermatological assessment; Clinical pilots achieved 40% more diverse enrollment in clinical trials

Clinical Focus

Lesion Detection; Clinical Research

Company Info

Business Model
SaaS
Founded
2024
Website
mymonitor.ai/

Categories

Precision Medicine/DiagnosticsAI / MLBlockchain

Disease Areas

Technologies

Multispectral ImagingCloud NativeAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

κ > 0.90 agreement with board-certified dermatologists; 60% faster diagnosis; melanin-compensated detection validated across diverse skin populations; live clinical pilots with Clinical Research of Philadelphia.

Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of MyMonitor.ai?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in MyMonitor.ai
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free